173 related articles for article (PubMed ID: 2220850)
1. Drug information services at Eli Lilly and Company.
Pfeil-Doyle JL; Jones MD; Oberlin JA; Benitez J
Am J Hosp Pharm; 1990 Sep; 47(9):1996-8. PubMed ID: 2220850
[No Abstract] [Full Text] [Related]
2. Understanding the resources and organization of an industry-based drug information service.
Colvin CL
Am J Hosp Pharm; 1990 Sep; 47(9):1989-90. PubMed ID: 2220847
[No Abstract] [Full Text] [Related]
3. FDA-USP drug product problem reporting program--an update.
Wheatley LS
Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
[No Abstract] [Full Text] [Related]
4. Drug information services at the Upjohn Company.
Baker RP; Gurwich EL; Depew CC
Am J Hosp Pharm; 1990 Sep; 47(9):1999-2001. PubMed ID: 2220852
[No Abstract] [Full Text] [Related]
5. Providing drug information to health professionals and consumers: role and responsibility of the pharmaceutical manufacturer.
Boyland JI
Hosp Pharm; 1983 Apr; 18(4):211-3, 216. PubMed ID: 10260207
[TBL] [Abstract][Full Text] [Related]
6. Bristol-Myers Squibb drug information department services.
Sylvan L; Palmer-Shevlin N
Hosp Pharm; 1995 Jan; 30(1):38-9, 44. PubMed ID: 10139729
[TBL] [Abstract][Full Text] [Related]
7. Sales reps: footsoldiers in drug company wars.
Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155
[No Abstract] [Full Text] [Related]
8. Drug information services at Pfizer labs.
Gasperino JL
Am J Hosp Pharm; 1990 Sep; 47(9):1998-9. PubMed ID: 2220851
[No Abstract] [Full Text] [Related]
9. Drug information services at Genentech.
Magnuson D; Buchanan J; Quan MP; Teichman S
Am J Hosp Pharm; 1990 Sep; 47(9):1993-5. PubMed ID: 2220849
[No Abstract] [Full Text] [Related]
10. Drug information services at Burroughs Wellcome Co.
Collins GE
Am J Hosp Pharm; 1990 Sep; 47(9):1991-3. PubMed ID: 2220848
[No Abstract] [Full Text] [Related]
11. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
[No Abstract] [Full Text] [Related]
12. [Detection of drug side effects at the Heidelberg Medical Clinic].
Jacubeit T; Drisch D
Verh Dtsch Ges Inn Med; 1989; 95():690-3. PubMed ID: 2603505
[No Abstract] [Full Text] [Related]
13. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser S
Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
[No Abstract] [Full Text] [Related]
14. Some aspects of drug monitoring.
Venulet J
Adverse Drug React Acute Poisoning Rev; 1985; 4(3):161-75. PubMed ID: 4061160
[No Abstract] [Full Text] [Related]
15. [Comprehensive detection of severe, potentially life-threatening drug side effects].
Schönhöfer PS; Wessely-Stickel B; Schulte-Sasse H; Werner W
Verh Dtsch Ges Inn Med; 1989; 95():687-90. PubMed ID: 2603504
[No Abstract] [Full Text] [Related]
16. [Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
Dahl E; Lindstrand G
Lakartidningen; 2005 Feb 28-Mar 6; 102(9):665. PubMed ID: 15804040
[No Abstract] [Full Text] [Related]
17. Update on drug information centers in the United States.
Rosenberg JM; Kirschenbaum HL; Labella NA
Am J Hosp Pharm; 1981 Oct; 38(10):1522-4. PubMed ID: 7294053
[No Abstract] [Full Text] [Related]
18. [Brief review of documents with data on the toxicity and hazards of chemical substances developed in various countries].
Sanotskiĭ IV; Smirnova ON
Gig Tr Prof Zabol; 1989; (3):33-6. PubMed ID: 2744552
[TBL] [Abstract][Full Text] [Related]
19. The patient information and education initiative.
Rheinstein PH; McGinnis TJ; Nightingale SL
Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726
[No Abstract] [Full Text] [Related]
20. The good gift: a comparison of the Eli Lilly presentation copies of Aequanimitas.
Kimbrough RC
J S C Med Assoc; 1995 Aug; 91(8):350-4. PubMed ID: 7674636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
